JARVISH Inc., an emerging global leader in smart 5G+AI+AR wearable devices, announced today that it has been qualified by Taiwan's NCSIST (National Chung-Shan Institute of Science and Technology)...

Infinity Pharmaceuticals, Inc. (NASDAQ: INFI), a clinical-stage biotechnology company developing IPI-549, a potentially first-in-class immuno-oncology product candidate that selectively inhibits...

Cesca Therapeutics Inc. (Nasdaq: KOOL), a market leader in automated cell processing and autologous cell therapies for regenerative medicine, today announced Jeff Cauble, Vice President of Finance...

Talent Board, a non-profit organization focused on the elevation and promotion of a quality candidate experience, today announced Talemetry, which combines the leading enterprise-grade recruitment...

Trovagene, Inc. (Nasdaq: TROV), a clinical-stage, Precision Cancer Medicine™ oncology therapeutics company developing drugs that target cell division (mitosis) for the treatment of various...